CAS: 2012536-16-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (2S,3R)-3-Hydroxy-2-((R)-5-isobutyryl-1-oxo-2,5-diazaspiro(3.4)octan-2-yl)butanamide REF: 3D-MFD53616CAS: 2012536-16-0 | Min. 95% | To inquire | Tue 21 Jan 25 |
 | NYX-2925 REF: TM-T73359CAS: 2012536-16-0 | - - - | 2,070.00 €~3,647.00 € | Tue 11 Mar 25 |
(2S,3R)-3-Hydroxy-2-((R)-5-isobutyryl-1-oxo-2,5-diazaspiro(3.4)octan-2-yl)butanamide
CAS:2012536-16-0
This is a research tool for the study of ion channels. It is an activator …
Formula:
C14H23N3O4
Purity:
Min. 95%
Molecular weight:
297.35 g/mol
Ref: 3D-MFD53616
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
NYX-2925
CAS:2012536-16-0
NYX-2925, an oral NMDAR modulator, enhances Src in mPFC. No CAMKII impact or addictive/sedative effects. …
Formula:
C14H23N3O4
Color and Shape:
Liquid
Molecular weight:
297.35
Ref: TM-T73359
| 25mg | 2,070.00 € | ||
| 50mg | 2,717.00 € | ||
| 100mg | 3,647.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
